Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TransMedics Group, Inc. - Common Stock
(NQ:
TMDX
)
146.00
+5.79 (+4.13%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TransMedics Group, Inc. - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
October 28, 2022
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test.
Via
MarketBeat
Topics
ETFs
Initial Public Offering
5 Analysts Have This to Say About TransMedics Group
↗
October 11, 2022
Analysts have provided the following ratings for TransMedics Group (NASDAQ:TMDX) within the last quarter:
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
September 20, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022
↗
August 02, 2022
Upgrades
Via
Benzinga
TransMedics Group: Q2 Earnings Insights
↗
August 01, 2022
TransMedics Group (NASDAQ:TMDX) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 01, 2022
Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.
Via
Benzinga
4 Analysts Have This to Say About TransMedics Group
↗
July 26, 2022
Over the past 3 months, 4 analysts have published their opinion on TransMedics Group (NASDAQ:TMDX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
Analyst Ratings for TransMedics Group
↗
July 26, 2022
Over the past 3 months, 4 analysts have published their opinion on TransMedics Group (NASDAQ:TMDX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 30, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
June 30, 2022
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!
Via
InvestorPlace
TransMedics Stock Skyrockets On Increased 2022 Guidance
↗
May 04, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
February 23, 2022
On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Earnings Scheduled For August 1, 2022
↗
August 01, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Via
Benzinga
81 Biggest Movers From Yesterday
↗
May 05, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5%
↗
May 04, 2022
U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision.
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
↗
May 04, 2022
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
May 04, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 03, 2022
Gainers
Via
Benzinga
TransMedics Group: Q1 Earnings Insights
↗
May 03, 2022
TransMedics Group (NASDAQ:TMDX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings TransMedics Group reported...
Via
Benzinga
Earnings Outlook For TransMedics Group
↗
May 02, 2022
TransMedics Group (NASDAQ:TMDX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
TransMedics Receives FDA Premarket Approval for OCS™ DCD Heart Indication
↗
April 28, 2022
TransMedics Group, Inc. (NASDAQ: TMDX) received premarket approval (PMA) from U.S. Food and Drug Administration (FDA) for its OCS™ Heart System in favour of use with organs from donors after...
Via
Benzinga
Earnings Scheduled For May 3, 2022
↗
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 06, 2022
Gainers
Via
Benzinga
88 Biggest Movers From Yesterday
↗
February 25, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Surges 2%; South Jersey Industries Shares Spike Higher
↗
February 24, 2022
U.S. stocks pared some earlier losses toward the end trading, with the Nasdaq jumping 2% on Thursday. US President Biden, during his press briefing on Ukraine/Russia, said he...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
February 24, 2022
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...
Via
Benzinga
Mid-Day Market Update: Dow Drops Over 500 Points; Crude Oil Surges 6%
↗
February 24, 2022
U.S. stocks remained lower midway through trading on Thursday after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
↗
February 24, 2022
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. (NYSE: CEI) rose 45.2% to $0....
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
↗
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
Recap: TransMedics Group Q4 Earnings
↗
February 23, 2022
TransMedics Group (NASDAQ:TMDX) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:05 PM. Here's what investors need to know about the announcement....
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today